119 related articles for article (PubMed ID: 36245030)
21. Targeting peptidylarginine deiminase reduces neutrophil extracellular trap formation and tissue injury in severe acute pancreatitis.
Madhi R; Rahman M; Taha D; Mörgelin M; Thorlacius H
J Cell Physiol; 2019 Jul; 234(7):11850-11860. PubMed ID: 30515825
[TBL] [Abstract][Full Text] [Related]
22. Increased citrullination and expression of peptidylarginine deiminases independently of P. gingivalis and A. actinomycetemcomitans in gingival tissue of patients with periodontitis.
Engström M; Eriksson K; Lee L; Hermansson M; Johansson A; Nicholas AP; Gerasimcik N; Lundberg K; Klareskog L; Catrina AI; Yucel-Lindberg T
J Transl Med; 2018 Jul; 16(1):214. PubMed ID: 30064459
[TBL] [Abstract][Full Text] [Related]
23. A novel role for peptidylarginine deiminases in microvesicle release reveals therapeutic potential of PAD inhibition in sensitizing prostate cancer cells to chemotherapy.
Kholia S; Jorfi S; Thompson PR; Causey CP; Nicholas AP; Inal JM; Lange S
J Extracell Vesicles; 2015; 4():26192. PubMed ID: 26095379
[TBL] [Abstract][Full Text] [Related]
24. Molecular targeting of protein arginine deiminases to suppress colitis and prevent colon cancer.
Witalison EE; Cui X; Causey CP; Thompson PR; Hofseth LJ
Oncotarget; 2015 Nov; 6(34):36053-62. PubMed ID: 26440311
[TBL] [Abstract][Full Text] [Related]
25. Activation of Peptidylarginine Deiminase in the Salivary Glands of
Rodríguez-Rodríguez M; Herrera-Esparza R; Bollain Y Goytia JJ; Pérez-Pérez ME; Pacheco-Tovar D; Murillo-Vázquez J; Pacheco-Tovar G; Avalos-Díaz E
J Immunol Res; 2017; 2017():8959687. PubMed ID: 29318161
[TBL] [Abstract][Full Text] [Related]
26. Peptidylarginine Deiminase Inhibitor Cl-Amidine Attenuates Cornification and Interferes with the Regulation of Autophagy in Reconstructed Human Epidermis.
Cau L; Takahara H; Thompson PR; Serre G; Méchin MC; Simon M
J Invest Dermatol; 2019 Sep; 139(9):1889-1897.e4. PubMed ID: 30878672
[TBL] [Abstract][Full Text] [Related]
27. LNS8801 inhibits Acute Myeloid Leukemia by Inducing the Production of Reactive Oxygen Species and Activating the Endoplasmic Reticulum Stress Pathway.
Lee I; Doepner M; Weissenrieder J; Majer AD; Mercado S; Estell A; Natale CA; Sung PJ; Foskett JK; Carroll MP; Ridky TW
Cancer Res Commun; 2023 Aug; 3(8):1594-1606. PubMed ID: 37599786
[TBL] [Abstract][Full Text] [Related]
28. HMGCS1 drives drug-resistance in acute myeloid leukemia through endoplasmic reticulum-UPR-mitochondria axis.
Zhou C; Li J; Du J; Jiang X; Xu X; Liu Y; He Q; Liang H; Fang P; Zhan H; Zeng H
Biomed Pharmacother; 2021 May; 137():111378. PubMed ID: 33601148
[TBL] [Abstract][Full Text] [Related]
29. Relative efficiencies of peptidylarginine deiminase 2 and 4 in generating target sites for anti-citrullinated protein antibodies in fibrinogen, alpha-enolase and histone H3.
Damgaard D; Bawadekar M; Senolt L; Stensballe A; Shelef MA; Nielsen CH
PLoS One; 2018; 13(8):e0203214. PubMed ID: 30161253
[TBL] [Abstract][Full Text] [Related]
30. Reduced Proteolipid Protein 2 promotes endoplasmic reticulum stress-related apoptosis and increases drug sensitivity in acute myeloid leukemia.
Xie F; Qu J; Lin D; Feng K; Tan M; Liao H; Zeng L; Xiong Q; Huang J; Chen W
Mol Biol Rep; 2023 Dec; 51(1):10. PubMed ID: 38085372
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic potential of GSK-J4, a histone demethylase KDM6B/JMJD3 inhibitor, for acute myeloid leukemia.
Li Y; Zhang M; Sheng M; Zhang P; Chen Z; Xing W; Bai J; Cheng T; Yang FC; Zhou Y
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1065-1077. PubMed ID: 29594337
[TBL] [Abstract][Full Text] [Related]
32. Evolving insights on histone methylome regulation in human acute myeloid leukemia pathogenesis and targeted therapy.
Boila LD; Sengupta A
Exp Hematol; 2020 Dec; 92():19-31. PubMed ID: 32950598
[TBL] [Abstract][Full Text] [Related]
33. Peptidylarginine Deiminase and Alzheimer's Disease.
Wang L; Chen H; Tang J; Guo Z; Wang Y
J Alzheimers Dis; 2022; 85(2):473-484. PubMed ID: 34842193
[TBL] [Abstract][Full Text] [Related]
34. VAS3947 Induces UPR-Mediated Apoptosis through Cysteine Thiol Alkylation in AML Cell Lines.
El Dor M; Dakik H; Polomski M; Haudebourg E; Brachet M; Gouilleux F; Prié G; Zibara K; Mazurier F
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751795
[TBL] [Abstract][Full Text] [Related]
35. An interplay of structure and intrinsic disorder in the functionality of peptidylarginine deiminases, a family of key autoimmunity-related enzymes.
Alghamdi M; Al Ghamdi KA; Khan RH; Uversky VN; Redwan EM
Cell Mol Life Sci; 2019 Dec; 76(23):4635-4662. PubMed ID: 31342121
[TBL] [Abstract][Full Text] [Related]
36. Peptidylarginine deiminase inhibition impairs Toll-like receptor agonist-induced functional maturation of dendritic cells, resulting in the loss of T cell-proliferative capacity: a partial mechanism with therapeutic potential in inflammatory settings.
Jang B; Kim HW; Kim JS; Kim WS; Lee BR; Kim S; Kim H; Han SJ; Ha SJ; Shin SJ
J Leukoc Biol; 2015 Feb; 97(2):351-62. PubMed ID: 25420918
[TBL] [Abstract][Full Text] [Related]
37. Novel combination of histone methylation modulators with therapeutic synergy against acute myeloid leukemia in vitro and in vivo.
Wen S; Wang J; Liu P; Li Y; Lu W; Hu Y; Liu J; He Z; Huang P
Cancer Lett; 2018 Jan; 413():35-45. PubMed ID: 29069576
[TBL] [Abstract][Full Text] [Related]
38. Peptidylarginine deiminase 2 is required for tumor necrosis factor alpha-induced citrullination and arthritis, but not neutrophil extracellular trap formation.
Bawadekar M; Shim D; Johnson CJ; Warner TF; Rebernick R; Damgaard D; Nielsen CH; Pruijn GJM; Nett JE; Shelef MA
J Autoimmun; 2017 Jun; 80():39-47. PubMed ID: 28188029
[TBL] [Abstract][Full Text] [Related]
39. Targeting the metabolic vulnerability of acute myeloid leukemia blasts with a combination of venetoclax and 8-chloro-adenosine.
Buettner R; Nguyen LXT; Morales C; Chen MH; Wu X; Chen LS; Hoang DH; Hernandez Vargas S; Pullarkat V; Gandhi V; Marcucci G; Rosen ST
J Hematol Oncol; 2021 Apr; 14(1):70. PubMed ID: 33902674
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and screening of a haloacetamidine containing library to identify PAD4 selective inhibitors.
Jones JE; Slack JL; Fang P; Zhang X; Subramanian V; Causey CP; Coonrod SA; Guo M; Thompson PR
ACS Chem Biol; 2012 Jan; 7(1):160-5. PubMed ID: 22004374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]